The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies ...

Amid multiple lawsuits against pharmacy benefit managers, a pair of bills have been filed in the 2026 Missouri legislative ...

The president simply doesn’t care that much about fixing this issue. So why is he bothering to pretend?

HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

11/14/2025 Motion to extend the time to file a response from December 1, 2025 to January 15, 2026, submitted to The Clerk. 11/14/2025 Response of Express Scripts, Inc., et al. to motion submitted.

The CEOs of the nation’s largest health insurers drew the ire of lawmakers on both sides of the aisle during congressional hearings that went for more than nine hours Jan. 22 over industry ...

Lawmakers on both sides of the aisle pressed health insurance CEOs on premium hikes, prior authorization rules and claim ...

Trump’s thinly sketched proposal, amounting to a few paragraphs on a website, calls for redirecting insurance subsidies into individual health-savings accounts, which could be used to purchase ...

The Non-Insured Health Benefits program covers things like prescription drugs and glasses for eligible First Nations people ...

A House committee found that CVS Health may have violated federal antitrust laws by threatening independent pharmacies to ...

HERCESSI™ becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

D: 8 p.m. ETThe House Ways and Means Committee hearing has concluded, bringing a long day of questioning for major health ...